Open AccessCHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy
Author(s) -
Alessandro Paoletti Perini,
Stefania Bartolini,
Paolo Pieragnoli,
Walter Ricciardi,
Laura Perrotta,
Alessandro Valleggi,
Giuseppe Vergaro,
Federica Michelotti,
Giulio Boggian,
Biagio Sassone,
Giosuè Mascioli,
Michele Emdin,
Luigi Padeletti
Publication year - 2013
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eut190
Subject(s) - medicine , cardiac resynchronization therapy , heart failure , atrial fibrillation , cardiology , stroke (engine) , implantable cardioverter defibrillator , intensive care medicine , ejection fraction , mechanical engineering , engineering
CHADS2 and CHA2DS2-VASc scores are pivotal in assessing the risk of stroke in atrial fibrillation patients, and were recently proved to predict hospitalizations and mortality in specific clinical settings. Aim of this study was to evaluate whether these scores could predict clinical outcomes [first hospitalization for heart failure (HF) and a combined event of HF hospitalization and death for any cause] in patients candidates to cardiac resynchronization therapy and implantable defibrillator (CRT-D).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom